Plasma PIVKA-II values as an indicator of AFP mRNA in the circulation in patients with advanced hepatocellular carcinoma

Hepatology Research

Volumn 8, Issue 1, 1997, Pages 28-36

  Nambu, Shuji ^a   Nishimori, Hiroshi ^a   Maekawa, Miyuki ^a   Higuchi, Kiyohiro ^a   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

AFP mRNA; Hepatocellular carcinoma; PIVKA II

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA; PLASMA PROTEIN; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030765729     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(97)00048-x     Document Type: Article

References (19)

1. Okuda K. Epidemiology of primary liver cancer. In: Tobe T., Kameda H., Okudaira M., Ohto M., Endo Y., Mito M., Okamoto E., Tanikawa K., Kojiro M., editors. Primary Liver Cancer in Japan. Tokyo: Springer-Verlag, 1992:3-15.
2. Okuda K. Advances in detection and treatment of liver cancer. In: Okuda K., Tobe T., Kltagawa T., editors. Early Detection and Treatment of Liver Cancer. Tokyo: Japan Scientific Society Press, 1991:3-14.
3. Liver Cancer Study of Japan. Survey and follow-up study of primary liver cancer in Japan, Report 10. Acta Hepatologica Japonica 1993;34:805-813.
4. Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1993;105:488-94.
5. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma. Hepatology 1994;21:403-7.
6. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y, Omata M. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994;20:1418-25.
7. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995;75:2214-9.
8. Nambu S, Nishimori H, Saski M, Higuchi K, Watanabe A. α-Fetoprotein messenger RNA in peripheral blood as a marker of circulating hepatocellular carcinoma cells. Int Hepatol Commun 1995;3:217-21.
9. Weitz I, Liebman A. Des-γ-carboxy prothrombin and hepatocellular carcinoma: A critical review. Hepatology 1993;18:990-7.
10. Hermanek P., Sobin L.H. UICC TNM classification of malignant tumors, 4th ed., 2nd rev. Berlin: Springer-Verlag, 1992.
11. Chromczynski P, Sacchi N. Single-step method of RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
12. Motohara K, Kuroki Y, Kan H, Endo F, Matsuda I. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354-7.
13. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 1989;64:1700-7.
14. Ebara M, Ohto M, Kondo F. Strategy for early diagnosis of hepatocellular carcinoma (HCC). Ann Acad Med Singapore 1989;18:83-9.
15. Okuda H, Obata H, Nakanishi T, Furukawa R, Hashimoto E. Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma: a clinical and experiment study. J Hepatol 1987;4:357-63.
16. Fujiyama S, Morishita T, Hashiguchi O, Sato T. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
17. Tanabe Y, Ohnishi K, Nomura F, Lida S. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma. Am J Gastroenterol 1988;83:1386-9.
18. Suzuki H., Akabane K., Tanaka M et al. Clinical evaluation of PIVKA-II kit (ED-036). Kan-Tan-Sui 1996;33:1069-1076 (in Japanese).
19. Soulier J-P, Gozin D, Lefrere J-J. A new method to assay des-γ-carboxy prothrombin: results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 1986;91:1258-62.